PROTACs-话题@MedSci - williamhill asia

#PROTACs#

4篇内容 | 527人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2219479, encodeId=c1bf22194e9a0, content=<a href='/topic/show?id=2392556299f' target=_blank style='color:#2F92EE;'>#抗肿瘤#</a> <a href='/topic/show?id=d3e3829103f' target=_blank style='color:#2F92EE;'>#肿瘤异质性#</a> <a href='/topic/show?id=9fd33e0829' target=_blank style='color:#2F92EE;'>#BRD4#</a> <a href='/topic/show?id=e78314e52c9' target=_blank style='color:#2F92EE;'>#PROTACs#</a>, objectTitle=中科院上海药物所《自然·通讯》：区域限制性PROTAC纳米平台，可实现时空可调的蛋白质降解和增强癌症治疗, objectType=article, longId=838018, objectId=abbd83801832, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240628/1719538044546_5579292.jpg, objectUrl=/article/show_article.do?id=abbd83801832, replyNumber=0, likeNumber=0, createdTime=14小时前, rootId=0, userName=williamhill asia 管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=abbd83801832, moduleTitle=中科院上海药物所《自然·通讯》：区域限制性PROTAC纳米平台，可实现时空可调的蛋白质降解和增强癌症治疗, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=abbd83801832)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=1791769, encodeId=7da01e91769b7, content=<a href='/topic/show?id=e78314e52c9' target=_blank style='color:#2F92EE;'>#PROTACs#</a>, objectTitle=综述：靶向蛋白降解(PROTACs)癌症治疗药物机制、以及新近进展、国内相关研发公司, objectType=article, longId=209142, objectId=df2420914253, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=df2420914253, replyNumber=0, likeNumber=49, createdTime=2021-10-22, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=df2420914253, moduleTitle=综述：靶向蛋白降解(PROTACs)癌症治疗药物机制、以及新近进展、国内相关研发公司, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=df2420914253)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1791770, encodeId=e57d1e917707a, content=<a href='/topic/show?id=e78314e52c9' target=_blank style='color:#2F92EE;'>#PROTACs#</a>, objectTitle=J Med Chem: 双PROTAC来了：我国学者首次提出双重靶向降解（Dual PROTACs）药物设计新概念, objectType=article, longId=212128, objectId=c3ae212128cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3ae212128cd, replyNumber=0, likeNumber=67, createdTime=2021-12-06, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3ae212128cd, moduleTitle=J Med Chem: 双PROTAC来了：我国学者首次提出双重靶向降解（Dual PROTACs）药物设计新概念, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=c3ae212128cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1791768, encodeId=72261e917685a, content=<a href='/topic/show?id=e78314e52c9' target=_blank style='color:#2F92EE;'>#PROTACs#</a>, objectTitle=Blood：CDK6特异性PROTACs选择性抑制Ph+ALL细胞生长, objectType=article, longId=187870, objectId=4a7018e87076, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4a7018e87076, replyNumber=0, likeNumber=59, createdTime=2020-10-30, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4a7018e87076, moduleTitle=Blood：CDK6特异性PROTACs选择性抑制Ph+ALL细胞生长, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=4a7018e87076)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1791767, encodeId=33491e9176700, content=<a href='/topic/show?id=e78314e52c9' target=_blank style='color:#2F92EE;'>#PROTACs#</a>, objectTitle=Nature:针对前列腺癌的PROTACs已进入临床试验！或将开启蛋白靶向降解治疗癌症新篇章！, objectType=article, longId=163067, objectId=e00716306e43, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e00716306e43, replyNumber=0, likeNumber=73, createdTime=2020-02-24, rootId=0, userName=zhaozuguo, userId=263b421, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e00716306e43, moduleTitle=Nature:针对前列腺癌的PROTACs已进入临床试验！或将开启蛋白靶向降解治疗癌症新篇章！, moduleType=article, hrefUrl=//www.nyrain.com/article/show_article.do?id=e00716306e43)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] williamhill asia 话题小助手

PROTACs

2020-05-29

williamhill asia 管理员 (审核中...)

前往app查看评论内容

#抗肿瘤# #肿瘤异质性# #BRD4# #PROTACs#

中科院上海药物所《自然·通讯》：区域限制性PROTAC纳米平台，可实现时空可调的蛋白质降解和增强癌症治疗

14小时前发表于上海

zhaozuguo (审核中...)

前往app查看评论内容

#PROTACs#

综述：靶向蛋白降解(PROTACs)癌症治疗药物机制、以及新近进展、国内相关研发公司

2021-10-22

zhaozuguo (审核中...)

前往app查看评论内容

#PROTACs#

J Med Chem: 双PROTAC来了：我国学者首次提出双重靶向降解（Dual PROTACs）药物设计新概念

2021-12-06

zhaozuguo (审核中...)

前往app查看评论内容

#PROTACs#

Blood：CDK6特异性PROTACs选择性抑制Ph+ALL细胞生长

2020-10-30

zhaozuguo (审核中...)

前往app查看评论内容

#PROTACs#

Nature:针对前列腺癌的PROTACs已进入临床试验！或将开启蛋白靶向降解治疗癌症新篇章！

2020-02-24

科室
- - 订阅+
  - 更多科室
工具
服务